Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06019455

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer Digestive System Diseases Digestive System Neoplasms Esophageal Cancer Esophageal Diseases Esophageal Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer.
  • Planned to undergo definitive chemoradiotherapy ± immunotherapy;
  • Males or females aged 18 to 75;
  • Able to communicate with medical staff.

Exclusion criteria

Patients with cognitive impairments.

Treatment and study plan

Primary outcomes

  1. Incidence of >=Grade 3 toxicities

    Time frame: 2 years

    The percentage of patients who develop >=Grade 3 toxicities

Secondary outcomes

  1. Overall survival

    Time frame: 2 years

    2-year survival rate

  2. Progression-free survival

    Time frame: 2 years

    2-year progression-free survival rate

Study contacts

Contact information is provided by the study sponsor or research team.

Bo Qiu

CONTACT

[email protected]

+862087343031

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Official study title

A Prospective Observational Study on the Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Aug 31, 2023
Registry last updated
Dec 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.